Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study


Muratori P., Efe C., Muratori L., Ozaslan E., Schiano T., Yoshida E. M., ...Daha Fazla

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.29, sa.7, ss.777-780, 2017 (SCI-Expanded) identifier identifier identifier

Özet

Background/aim Antimitochondrial antibody (AMA) positivity is the serological marker of primary biliary cholangitis (PBC), but can also be sporadically detected in autoimmune hepatitis (AIH). Little is known about the clinical significance of AMA in AIH.